Coherus BioSciences, Inc. Quarterly Current Ratio in % from Q2 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Coherus BioSciences, Inc. quarterly Current Ratio history and growth rate from Q2 2015 to Q2 2024.
  • Coherus BioSciences, Inc. Current Ratio for the quarter ending June 30, 2024 was 134 %, a 47.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 134 -120 -47.3% Jun 30, 2024
Q1 2024 151 -126 -45.5% Mar 31, 2024
Q4 2023 188 -108 -36.6% Dec 31, 2023
Q3 2023 228 -90.9 -28.6% Sep 30, 2023
Q2 2023 254 -32.5 -11.3% Jun 30, 2023
Q1 2023 277 +13.1 +4.96% Mar 31, 2023
Q4 2022 296 +48.2 +19.4% Dec 31, 2022
Q3 2022 318 +49.5 +18.4% Sep 30, 2022
Q2 2022 286 -50.1 -14.9% Jun 30, 2022
Q1 2022 264 -154 -36.8% Mar 31, 2022
Q4 2021 248 -238 -49% Dec 31, 2021
Q3 2021 269 -162 -37.6% Sep 30, 2021
Q2 2021 336 -42.2 -11.1% Jun 30, 2021
Q1 2021 418 +95.4 +29.5% Mar 31, 2021
Q4 2020 486 +158 +48.3% Dec 31, 2020
Q3 2020 431 +98.7 +29.7% Sep 30, 2020
Q2 2020 379 +17.4 +4.82% Jun 30, 2020
Q1 2020 323 -127 -28.3% Mar 31, 2020
Q4 2019 328 -137 -29.4% Dec 31, 2019
Q3 2019 332 -214 -39.2% Sep 30, 2019
Q2 2019 361 -188 -34.2% Jun 30, 2019
Q1 2019 450 -21.9 -4.63% Mar 31, 2019
Q4 2018 464 -10 -2.11% Dec 31, 2018
Q3 2018 546 +140 +34.4% Sep 30, 2018
Q2 2018 549 +195 +55.2% Jun 30, 2018
Q1 2018 472 +182 +62.8% Mar 31, 2018
Q4 2017 474 +225 +90.4% Dec 31, 2017
Q3 2017 406 +181 +80.4% Sep 30, 2017
Q2 2017 354 +139 +65.1% Jun 30, 2017
Q1 2017 290 +51.5 +21.6% Mar 31, 2017
Q4 2016 249 +1.02 +0.41% Dec 31, 2016
Q3 2016 225 -68.4 -23.3% Sep 30, 2016
Q2 2016 214 -93.1 -30.3% Jun 30, 2016
Q1 2016 238 Mar 31, 2016
Q4 2015 248 Dec 31, 2015
Q3 2015 294 Sep 30, 2015
Q2 2015 307 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.